Joysoual, M. R., Ara, S., Razzaque, S., & Islam, M. (2026). Safety of Empagliflozin as Add-on Therapy in Patients with Uncontrolled Type 2 Diabetes Mellitus. KYAMC Journal, 16(3), 119–122. https://doi.org/10.3329/kyamcj.v16i3.88022